
1. J Natl Cancer Inst. 2010 Mar 3;102(5):358-9; author reply 359-60.

Response: Re: Cost-effectiveness analysis of human papillomavirus vaccination in 
the Netherlands.

Rozenbaum MH, Boersma C.

Comment on
    J Natl Cancer Inst. 2009 Aug 5;101(15):1083-92.

DOI: 10.1093/jnci/djp519 
PMID: 20229619  [Indexed for MEDLINE]

